The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.

The field of medical diagnostics and clinical practice is being transformed by the rapid advancement of deep learning ...

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for Pharmacoeconomics ...

The increasing demand for advanced medical technologies and ongoing innovations has intensified the requirement for specialized regulatory expertise. VANCOUVER, BRITISH COLUMBIA, CANADA, May 13, 2025 ...

A Rutgers Health review of 151 studies finds that minimizing unexplained symptoms sparks shame, trauma and avoidance of care.

The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start ...

The global Artificial Intelligence (AI) in Healthcare Market, valued at US$14.92 billion in 2024, is forecasted to grow at a robust CAGR of 38.6%, reaching US$21.66 billion in 2025 and an impressive ...

(IN BRIEF) SGS Belgium NV has been designated as a Notified Body under the EU’s In Vitro Diagnostic Medical Device Regulation (IVDR), expanding Europe’s limited capacity for regulatory assessments.

A diagnostic medical sonographer could be answering the question "Is it a boy or a girl?" as well as a host of other life-changing medical questions with the help of ultrasound technology.